Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × Nivolumab × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 28 Carcinoma, Non-Small-Cell Lung 19 Carcinoma, Renal Cell 16 Neoplasm Metastasis 11 Lung Neoplasms 11 Stomach Neoplasms 9 Urinary Bladder Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Carcinoma, Transitional Cell 7 Carcinoma, Hepatocellular 7 Adenocarcinoma Of Esophagus 7 Skin Neoplasms 6 Carcinoma, Merkel Cell 6 Ovarian Neoplasms 5 Neoplasms 5 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Glioblastoma 4 Breast Neoplasms 4 Uveal Melanoma 3 Urethral Neoplasms 3 Prostatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Myelodysplastic Syndromes 3 Mouth Neoplasms 3 Liver Neoplasms 3 Hodgkin Disease 3 Esophageal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3

Interventions

Oxaliplatin 9 Cetuximab 8 Bevacizumab 7 pembrolizumab 5 Leucovorin 5 Fluorouracil 5 Irinotecan 4 Pemetrexed 3 Gemcitabine 3 Cisplatin 3 Carboplatin 3 Capecitabine 3 fludarabine 2 adagrasib 2 Specimen Handling 2 Paclitaxel 2 Folfox protocol 2 Cyclophosphamide 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 sintilimab 1 ropidoxuridine 1 relatlimab 1 palbociclib 1 encorafenib 1 durvalumab 1 dostarlimab 1 dehydroftorafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03026140 2026-03-05

NICHE

The Netherlands Cancer Institute

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡